MMP9 and neoplasm: IHC showed that the five markers, HYAL-1, HAS-2, N-Cadh, Slug, and MMP-9 included in the CM-6 signature, were upregulated in tumor tissues from patients who developed metastasis compared to normal colon tissues and in tumors from patients who did not develop metastasis (Figure 3D).